17^th International Virology Summit

Viral Oncology

Viral oncology is a subdivision of oncology,in these it is concerned with treatment of  human cancers /tumors with virus particles. Approximately 20% of all cancers worldwide results from chronic infections, in specific, up to 15% of human cancers is characterized by a viral aetiology with higher incidence in Developing Countries. Certainly, the infectious nature of specific tumors has important implications in their prevention, diagnosis, and therapy. In the 21st Century, the research on viral oncology field continues to be dynamic, with new significant and original studies on viral oncogenesis and as a translational research from virology for the treatment of cancer.These disruptions can cause cells to become malignant and evade the immune system. In other cases, such as with HBV and HCV, the persistent inflammation and liver damage caused by chronic viral infections can result in genetic mutations and changes in the cellular environment that facilitate tumorigenesis. Understanding the role of viruses in cancer has led to important advancements in preventive measures, such as the development of vaccines. The HPV vaccine is an effective measure to prevent cervical cancer and other HPV-related cancers. Vaccines against HBV have also significantly reduced the risk of liver cancer in regions where the virus is endemic. Furthermore, antiviral treatments for chronic infections like HCV can reduce the risk of developing liver cancer, emphasizing the importance of early diagnosis and treatment in viral oncology.